Market Overview:
The global blood glucose monitoring devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, technological advancements in blood glucose monitoring devices, and rising demand for home-care settings. Based on type, the global blood glucose monitoring devices market is segmented into self-monitoring devices and continuous glucose monitoring (CGM) devices. The self-monitoring devices segment is further divided into manual testing meters and automated testing meters. The CGM Devices segment is further sub-segmented into implantable CGMs and non-implantable CGMs. Based on application, the global blood sugar monitoring device market is divided into hospitals & diagnostic laboratories, point of care (POL), and home care settings. Geographically, the global Blood Glucose Monitoring Devices Market has been segregated into five major regions: North America, Latin America, Europe Asia Pacific ,and Middle East & Africa .
Product Definition:
Blood glucose monitoring devices are used to measure blood sugar levels. They are important for people with diabetes, as they can help to ensure that blood sugar levels stay within a healthy range.
Self-Monitoring Devices:
Self-monitoring devices, also known as wearable medical devices or personal glucose meters are used to measure blood sugar levels. They are small in size and can be worn on the body like a wristwatch. These devices have advanced features such as wireless communication, large LCD screens with backlight and easy to use options for both patients and doctors.
Continuous Glucose Monitoring Devices:
Continuous glucose monitoring (CGM) devices are medical devices used to measure blood sugar levels in humans. These continuous glucose monitors or CGMs are small portable instruments that help in measuring the blood sugar level of a patient on-the-go, at any time and any place.
Application Insights:
The market is segmented into hospitals and diagnostic laboratories, POL, home-care settings, and others. The hospital and diagnostic laboratories segment dominated the global market in 2017 owing to the rising prevalence of diabetes coupled with a growing number of product launches by prominent players in the market. For instance, in January 2018 glucoremetters launched new self-monitoring glucose devices including G6 One Touch Glucose Meters & Insulin Pumps which has been designed for patients requiring one-button operation with large LCD display screen.
The home-care settings segment is expected to grow at a lucrative rate over the forecast period due to increasing awareness about controlling blood sugar levels among people living with diabetes as well as growing demand for point of care solutions that enable easy monitoring without healthcare professional intervention or assistance required while using these devices at home. Furthermore, technological advancements such as integration of artificial intelligence along with self-monitoring glucose devices are anticipated to further boost growth over next few years.
Regional Analysis:
North America dominated the global blood glucose monitoring devices market in 2017. This can be attributed to the presence of a large patient pool, favorable reimbursement policies, and increasing awareness about new technologies. The U.S., which is at the forefront of this region, has one of the highest incidences of diabetes in the world with around 9 million people suffering from diabetes out of which 60% are diagnosed while 40% are left undiagnosed leading to severe consequences such as kidney failure or blindness (Diabetic retinopathy). Thus, raising awareness levels among individuals suffering from diabetes is expected to boost product demand over next eight years.
Asia Pacific region is anticipated to witness lucrative growth during forecast period owing to rising disposable income and improving healthcare infrastructure especially in developing countries such as India and China along with other Southeast Asian nations that have a high diabetic population ratio due to unhealthy lifestyles adopted by its inhabitants including heavy consumption off-course beverages like tea.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is expected to drive the demand for blood glucose monitoring devices in the coming years.
- Technological advancements: The development of novel and innovative blood glucose monitoring devices is helping to improve the accuracy and convenience of these devices. This is likely to boost the growth of the market in the coming years.
- Growing awareness about diabetes: There has been a growing awareness about diabetes in recent years, owing to which people are increasingly opting for blood glucose monitoring devices for early diagnosis and treatment of this disease condition.
Scope Of The Report
Report Attributes
Report Details
Report Title
Blood Glucose Monitoring Devices Market Research Report
By Type
Self-Monitoring Devices, Continuous Glucose Monitoring Devices
By Application
Hospitals and Diagnostic Laboratories, POL, Home-Care Settings
By Companies
Terumo Corporation, Acon Laboratories, Roche Diagnostics, Johnson＆Johnson, ARKRAY, Novo Nordisk, Medtronic, Abbott Laboratories, Ypsomed, Sanofi, Terumo Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Blood Glucose Monitoring Devices Market Report Segments:
The global Blood Glucose Monitoring Devices market is segmented on the basis of:
Types
Self-Monitoring Devices, Continuous Glucose Monitoring Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Diagnostic Laboratories, POL, Home-Care Settings
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Terumo Corporation
- Acon Laboratories
- Roche Diagnostics
- Johnson＆Johnson
- ARKRAY
- Novo Nordisk
- Medtronic
- Abbott Laboratories
- Ypsomed
- Sanofi
- Terumo Corporation
Highlights of The Blood Glucose Monitoring Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Self-Monitoring Devices
- Continuous Glucose Monitoring Devices
- By Application:
- Hospitals and Diagnostic Laboratories
- POL
- Home-Care Settings
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Blood Glucose Monitoring Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Blood glucose monitoring devices are medical devices that measure the level of blood glucose. Blood glucose monitors can be used to diagnose and monitor diabetes, to assess the effectiveness of diabetes treatments, and to predict complications in people with diabetes.
Some of the major companies in the blood glucose monitoring devices market are Terumo Corporation, Acon Laboratories, Roche Diagnostics, Johnson¯Â¼â€ Johnson, ARKRAY, Novo Nordisk, Medtronic, Abbott Laboratories, Ypsomed, Sanofi, Terumo Corporation.
The blood glucose monitoring devices market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Blood Glucose Monitoring Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Blood Glucose Monitoring Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Blood Glucose Monitoring Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Blood Glucose Monitoring Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Blood Glucose Monitoring Devices Market Size & Forecast, 2018-2028
4.5.1 Blood Glucose Monitoring Devices Market Size and Y-o-Y Growth
4.5.2 Blood Glucose Monitoring Devices Market Absolute $ Opportunity
Chapter 5 Global Blood Glucose Monitoring Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Blood Glucose Monitoring Devices Market Size Forecast by Type
5.2.1 Self-Monitoring Devices
5.2.2 Continuous Glucose Monitoring Devices
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Blood Glucose Monitoring Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Blood Glucose Monitoring Devices Market Size Forecast by Applications
6.2.1 Hospitals and Diagnostic Laboratories
6.2.2 POL
6.2.3 Home-Care Settings
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Blood Glucose Monitoring Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Blood Glucose Monitoring Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Blood Glucose Monitoring Devices Analysis and Forecast
9.1 Introduction
9.2 North America Blood Glucose Monitoring Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Blood Glucose Monitoring Devices Market Size Forecast by Type
9.6.1 Self-Monitoring Devices
9.6.2 Continuous Glucose Monitoring Devices
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Blood Glucose Monitoring Devices Market Size Forecast by Applications
9.10.1 Hospitals and Diagnostic Laboratories
9.10.2 POL
9.10.3 Home-Care Settings
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Blood Glucose Monitoring Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Blood Glucose Monitoring Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Blood Glucose Monitoring Devices Market Size Forecast by Type
10.6.1 Self-Monitoring Devices
10.6.2 Continuous Glucose Monitoring Devices
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Blood Glucose Monitoring Devices Market Size Forecast by Applications
10.10.1 Hospitals and Diagnostic Laboratories
10.10.2 POL
10.10.3 Home-Care Settings
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Blood Glucose Monitoring Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Blood Glucose Monitoring Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Blood Glucose Monitoring Devices Market Size Forecast by Type
11.6.1 Self-Monitoring Devices
11.6.2 Continuous Glucose Monitoring Devices
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Blood Glucose Monitoring Devices Market Size Forecast by Applications
11.10.1 Hospitals and Diagnostic Laboratories
11.10.2 POL
11.10.3 Home-Care Settings
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Blood Glucose Monitoring Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Blood Glucose Monitoring Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Blood Glucose Monitoring Devices Market Size Forecast by Type
12.6.1 Self-Monitoring Devices
12.6.2 Continuous Glucose Monitoring Devices
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Blood Glucose Monitoring Devices Market Size Forecast by Applications
12.10.1 Hospitals and Diagnostic Laboratories
12.10.2 POL
12.10.3 Home-Care Settings
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Blood Glucose Monitoring Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Blood Glucose Monitoring Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Blood Glucose Monitoring Devices Market Size Forecast by Type
13.6.1 Self-Monitoring Devices
13.6.2 Continuous Glucose Monitoring Devices
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Blood Glucose Monitoring Devices Market Size Forecast by Applications
13.10.1 Hospitals and Diagnostic Laboratories
13.10.2 POL
13.10.3 Home-Care Settings
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Blood Glucose Monitoring Devices Market: Competitive Dashboard
14.2 Global Blood Glucose Monitoring Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Terumo Corporation
14.3.2 Acon Laboratories
14.3.3 Roche Diagnostics
14.3.4 Johnson＆Johnson
14.3.5 ARKRAY
14.3.6 Novo Nordisk
14.3.7 Medtronic
14.3.8 Abbott Laboratories
14.3.9 Ypsomed
14.3.10 Sanofi
14.3.11 Terumo Corporation
